Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Neurotrophin signaling pathway	6/119	1.8026532893354827e-09	1.910812486695612e-07	105.59734513274336	-308.64732996592954	HRAS;KRAS;MAP2K7;PTPN11;RAF1;SOS1
KEGG_2021_Human	Fc epsilon RI signaling pathway	5/68	8.88126377354054e-09	3.381450163235346e-07	127.06349206349206	-315.4298190501735	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Renal cell carcinoma	5/69	9.57014197142079e-09	3.381450163235346e-07	125.0625	-311.8276859869734	HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Chronic myeloid leukemia	5/76	1.5675128124076017e-08	4.153908952880145e-07	112.63380281690141	-288.85723035226965	HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	ErbB signaling pathway	5/85	2.7700815895920385e-08	5.872572969935121e-07	99.85	-264.06979173492016	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	GnRH signaling pathway	5/93	4.370736564994153e-08	7.721634598156338e-07	90.68181818181819	-245.48357760337638	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	T cell receptor signaling pathway	5/104	7.689793164389816e-08	1.1644543934647436e-06	80.4949494949495	-223.94034919826578	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Ras signaling pathway	6/232	1.0038183269047773e-07	1.33005928314883e-06	52.04867256637168	-174.3857646205266	HRAS;KRAS;NF1;PTPN11;RAF1;SOS1
KEGG_2021_Human	Relaxin signaling pathway	5/129	2.2716633239535927e-07	2.600940128869283e-06	64.06451612903226	-186.88656585734114	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	5/131	2.453717102706871e-07	2.600940128869283e-06	63.03174603174603	-184.44906174375365	HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	MAPK signaling pathway	6/294	4.1027904082915563e-07	3.953598029808227e-06	40.520833333333336	-140.03790468986205	HRAS;KRAS;MAP2K7;NF1;RAF1;SOS1
KEGG_2021_Human	Phospholipase D signaling pathway	5/148	4.5165846521694494e-07	3.967959680403366e-06	55.41958041958042	-166.03116096912797	HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Endometrial cancer	4/58	4.866365645777712e-07	3.967959680403366e-06	98.93827160493827	-213.9782421683718	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Hepatitis B	5/162	7.08729574350555e-07	5.366095348654202e-06	50.388535031847134	-153.38399251928269	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Acute myeloid leukemia	4/67	8.744364582866104e-07	6.179350971892047e-06	84.70899470899471	-190.62775527188097	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Prolactin signaling pathway	4/70	1.044163095458912e-06	6.917580507415293e-06	80.82828282828282	-183.98664919066243	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Non-small cell lung cancer	4/72	1.1701896109043542e-06	7.296476397403621e-06	78.43137254901961	-179.82105034024002	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Glioma	4/75	1.3800270600312918e-06	8.126826020184274e-06	75.08920187793427	-173.9277482736146	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	B cell receptor signaling pathway	4/81	1.8822504670820177e-06	1.050097629003652e-05	69.18614718614718	-163.26311048820392	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Proteoglycans in cancer	5/205	2.2782064363203903e-06	1.2074494112498067e-05	39.34	-124.0582853403489	HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Colorectal cancer	4/86	2.39527906270035e-06	1.2090456221249385e-05	64.92682926829268	-155.35089438097907	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Gap junction	4/88	2.627125268929808e-06	1.265796720484362e-05	63.36507936507937	-152.4012036590114	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	2.7491085630604124e-06	1.2669804681930596e-05	62.61176470588235	-150.9687540546772	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	Prostate cancer	4/97	3.882535399026648e-06	1.7147864679034364e-05	57.168458781362006	-140.4227070470985	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Choline metabolism in cancer	4/98	4.045325673294005e-06	1.715218085476658e-05	56.5531914893617	-139.20816886591868	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	C-type lectin receptor signaling pathway	4/104	5.130876847568527e-06	2.0918190224702454e-05	53.12	-132.3420645012429	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	Growth hormone synthesis, secretion and action	4/119	8.781438908516766e-06	3.4475278677880635e-05	46.10434782608696	-117.80575201518995	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	FoxO signaling pathway	4/131	1.286407583499158e-05	4.8699715661039554e-05	41.68503937007874	-108.26148696115065	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Bladder cancer	3/41	1.4210039899252074e-05	5.1940145838645516e-05	90.56390977443608	-146.56914663391532	HRAS;KRAS;RAF1
KEGG_2021_Human	Insulin signaling pathway	4/137	1.5363738345825308e-05	5.253407305346718e-05	39.774436090225564	-104.03256013781805	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Estrogen signaling pathway	4/137	1.5363738345825308e-05	5.253407305346718e-05	39.774436090225564	-104.03256013781805	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Breast cancer	4/147	2.0304341193526998e-05	6.725813020355818e-05	36.946386946386944	-97.65028859286629	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Gastric cancer	4/149	2.14182517183331e-05	6.879802067100937e-05	36.42758620689655	-96.46283757609443	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	mTOR signaling pathway	4/154	2.4400135505395987e-05	7.607101069329338e-05	35.19111111111111	-93.61108375071908	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Hepatitis C	4/157	2.633008128708365e-05	7.974253189802477e-05	34.4880174291939	-91.97557482769783	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	JAK-STAT signaling pathway	4/162	2.979383554686203e-05	8.772629355464932e-05	33.37552742616034	-89.36652156273904	HRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Hepatocellular carcinoma	4/168	3.4380880466544094e-05	9.849657647172092e-05	32.13008130081301	-86.4138745753221	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	VEGF signaling pathway	3/59	4.2829644076396207e-05	0.00011947216505521048	61.316326530612244	-109.395777314067	HRAS;KRAS;RAF1
KEGG_2021_Human	Long-term depression	3/60	4.505443332381932e-05	0.00012245563929038072	60.233082706766915	-107.89522342261756	HRAS;KRAS;RAF1
KEGG_2021_Human	Axon guidance	4/182	4.708801155471762e-05	0.0001247832306200017	29.55056179775281	-80.18631081942894	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	Alcoholism	4/186	5.12791409046896e-05	0.0001325753398999292	28.886446886446887	-78.55734579098154	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	GnRH secretion	3/64	5.4712305971300705e-05	0.0001380834388799494	56.25526932084309	-102.29382199022506	HRAS;KRAS;RAF1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	4/193	5.926501543349045e-05	0.00014277480990795426	27.79188712522046	-75.84859252655446	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Chemokine signaling pathway	4/192	5.8071760943932126e-05	0.00014277480990795426	27.94326241134752	-76.22501680035803	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Long-term potentiation	3/67	6.278481738010982e-05	0.00014789312538425868	53.598214285714285	-98.46843432757142	HRAS;KRAS;RAF1
KEGG_2021_Human	Central carbon metabolism in cancer	3/70	7.160249860764975e-05	0.00016499706200893204	51.17910447761194	-94.92366080084827	HRAS;KRAS;RAF1
KEGG_2021_Human	Melanoma	3/72	7.791014338658423e-05	0.0001757122382761261	49.683229813664596	-92.7008152698569	HRAS;KRAS;RAF1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	8.553680416035766e-05	0.00018889377585412317	25.192307692307693	-69.28980198257669	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Regulation of actin cytoskeleton	4/218	9.536789533388116e-05	0.0002063060592937021	24.46728971962617	-67.4274609186936	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.00022865417524569625	23.671191553544496	-65.36509727839072	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Chemical carcinogenesis	4/239	0.00013636702582860217	0.0002834295046633692	22.22127659574468	-61.560372574383265	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Melanogenesis	3/101	0.00021361559897150326	0.0004354471825188336	34.85422740524781	-69.18688807277512	HRAS;KRAS;RAF1
KEGG_2021_Human	Serotonergic synapse	3/113	0.00029777417443940563	0.0005955483488788113	31.005194805194805	-62.561773808196286	HRAS;KRAS;RAF1
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.0006809093190614318	29.379310344827587	-59.68521503911596	HRAS;KRAS;RAF1
KEGG_2021_Human	Thyroid hormone signaling pathway	3/121	0.00036434044298052937	0.0007021833991988385	28.87409200968523	-58.78131250266827	HRAS;KRAS;RAF1
KEGG_2021_Human	MicroRNAs in cancer	4/310	0.00037183876854062896	0.0007038376690233334	16.910675381263616	-47.03626387241228	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Human papillomavirus infection	4/331	0.0004777466484480537	0.0008884411357104157	15.781855249745158	-43.81753827074924	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Autophagy	3/137	0.0005248515914701949	0.0009429537067091637	25.375266524520256	-52.38188378130509	HRAS;KRAS;RAF1
KEGG_2021_Human	Apelin signaling pathway	3/137	0.0005248515914701949	0.0009429537067091637	25.375266524520256	-52.38188378130509	HRAS;KRAS;RAF1
KEGG_2021_Human	Apoptosis	3/142	0.0005829830335043062	0.0010299366925242744	24.447070914696813	-50.640785217242495	HRAS;KRAS;RAF1
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	3/143	0.0005950854077497673	0.001034082839696317	24.26938775510204	-50.30529409222555	HRAS;KRAS;RAF1
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.0010549418776271988	14.700952380952382	-40.688114366493096	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Alzheimer disease	4/369	0.0007223109472324288	0.001215316831851388	14.069406392694065	-38.837531411044004	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Oxytocin signaling pathway	3/154	0.0007390260491982426	0.0012240118939845894	22.47019867549669	-46.86692877135684	HRAS;KRAS;RAF1
KEGG_2021_Human	Cellular senescence	3/156	0.0007673816433603202	0.0012514223722491376	22.170868347338935	-46.2873867313738	HRAS;KRAS;RAF1
KEGG_2021_Human	Thyroid cancer	2/37	0.0008976760152685225	0.0014417220851282331	57.378571428571426	-64.24352876962546	HRAS;KRAS
KEGG_2021_Human	Focal adhesion	3/201	0.0016005928499043844	0.002532281225221862	17.034632034632036	-35.97452728368245	HRAS;RAF1;SOS1
KEGG_2021_Human	Rap1 signaling pathway	3/210	0.001815768220475436	0.0028304622260352384	16.27536231884058	-34.3854987417392	HRAS;KRAS;RAF1
KEGG_2021_Human	Pathways of neurodegeneration	4/475	0.0018650609703256306	0.002865166128326331	10.753007784854919	-28.8390927430974	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.0029420002654769006	15.881401617250674	-33.55383703082171	HRAS;KRAS;MAP2K7
KEGG_2021_Human	Thermogenesis	3/232	0.0024164136009215383	0.0036076034041927192	14.670617592014972	-30.966105875434415	HRAS;KRAS;SOS1
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.004147762732465637	9.539531941808981	-25.060320343159585	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.0042934903628309255	13.627177700348431	-28.69609856443984	HRAS;MAP2K7;RAF1
KEGG_2021_Human	Mitophagy	2/68	0.0030081604419031007	0.004308986578942279	30.310606060606062	-38.524679686703344	HRAS;KRAS
KEGG_2021_Human	Pancreatic cancer	2/76	0.0037436519554145367	0.005291028096985879	27.006756756756758	-34.90410589940028	KRAS;RAF1
KEGG_2021_Human	Progesterone-mediated oocyte maturation	2/100	0.006399778215208473	0.008810084296261015	20.331632653061224	-27.120602948412195	KRAS;RAF1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.008810084296261015	20.331632653061224	-27.120602948412195	HRAS;KRAS
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.009038330976966899	19.92	-26.61700675496218	HRAS;KRAS
KEGG_2021_Human	Cholinergic synapse	2/113	0.008111349626545349	0.010883583043212748	17.92117117117117	-24.127023560492017	HRAS;KRAS
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.03281009198797047	9.784825870646767	-13.073912909097736	HRAS;KRAS
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.0373308979965656	9.044930875576037	-11.980722307867735	HRAS;KRAS
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	1/37	0.04489527895199197	0.05803536059647742	24.790123456790123	-13.876145105511855	KRAS
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.10504433979371812	13.071895424836601	-7.854937277937848	PTPN11
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.1052398238630736	12.880837359098228	-7.74542097629872	PTPN11
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	1/97	0.11385418156418702	0.14198286171533908	9.226851851851851	-5.553951626329874	RAF1
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.14987927117132147	8.592233009708737	-5.152341092635986	MAP2K7
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.1508393156062569	8.426455026455027	-5.046288872333345	RAF1
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.15177155557597005	8.2668743509865	-4.943743954376122	PTPN11
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.15528172887199762	7.964964964964965	-4.748494648054986	MAP2K7
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.15612640581752618	7.822025565388397	-4.655477238055189	PTPN11
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.17079291130033952	7.00352733686067	-4.115510268264927	MAP2K7
KEGG_2021_Human	Vascular smooth muscle contraction	1/133	0.1530456645682748	0.17633522221996878	6.68013468013468	-3.898639281229232	RAF1
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.17929103328857612	6.480392156862745	-3.763669230249352	MAP2K7
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.17977566606186537	6.384863123993559	-3.698840756963446	MAP2K7
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.20955185159602657	5.131254061078622	-2.8313674486945275	RAF1
KEGG_2021_Human	cGMP-PKG signaling pathway	1/167	0.1886201000678787	0.20955185159602657	5.289156626506024	-2.942334294710352	RAF1
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.20955185159602657	5.224867724867725	-2.8972129419331236	MAP2K7
KEGG_2021_Human	Protein processing in endoplasmic reticulum	1/171	0.19271564324144907	0.20955185159602657	5.162091503267974	-2.8530763101358976	MAP2K7
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.21613578729778538	4.896958410924891	-2.6658400097237527	RAF1
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.22357129084052663	4.657210401891253	-2.4954112144854435	RAF1
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.2297222395883176	4.462585034013605	-2.3563138595912863	PTPN11
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.23260832536792472	4.3488114980652295	-2.274707784911856	MAP2K7
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.24444360709124388	4.058397932816537	-2.065502377074288	RAF1
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.27697341670773756	3.4603806994245243	-1.6315316807371463	HRAS
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.32354505199314565	2.8280510018214935	-1.1715156192121785	MAP2K7
KEGG_2021_Human	Herpes simplex virus 1 infection	1/498	0.4709527127104428	0.4709527127104428	1.6926000447127207	-0.379898711570649	PTPN11
